Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | MMP12 | P39900 | 3/20 | 0.53 |
| ▸ | MMP2 | P08253 | 1/20 | 0.53 |
| ▸ | MMP9 | P14780 | 1/20 | 0.53 |
| ▸ | MMP13 | P45452 | 1/20 | 0.53 |
| ▸ | MMP14 | P50281 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.50 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2478370 | 1.00 | TSHR (0.54) | TSHRMMP12MMP2MMP9MMP13 | |
| SCHEMBL26837610 | 1.00 | TSHR (0.54) | TSHRMMP12MMP2MMP9MMP13 | |
| Nitrous Acid SCHEMBL26607946 | 0.93 | TSHR (0.49) | TSHRMMP12MMP2MMP9MMP13 | |
| SCHEMBL11875805 | 0.90 | MMP12 (0.69) | TSHRMMP12MMP2MMP9MMP13 | |
| SCHEMBL5074784 | 0.86 | MAPT (0.56) | KMT2ASMN1; SMN2HPGD | |
| SCHEMBL14016007 | 0.86 | MAPT (0.56) | KMT2ASMN1; SMN2HPGD | |
| SCHEMBL661213 | 0.85 | TSHR (0.51) | TSHRMEN1HTTKMT2ASMN1; SMN2 | |
| SCHEMBL25954987 | 0.85 | FFAR1 (0.47) | MMP12MMP2MMP9MMP13MMP14 | |
| SCHEMBL11578170 | 0.85 | ALDH1A1 (0.53) | TSHRMMP12MMP2MMP9MMP13 | |
| SCHEMBL7621975 | 0.84 | GAA (0.45) | MMP12MMP2MMP9MMP13MMP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6844302-B1 | Encapsulated flavor and fragrance | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2005-01-18 | — | — | US | claimed |
| US-12630781-B2 | Fragrance or flavour mixture | SYMRISE AG (DE) | 2026-05-19 | — | — | US | disclosed |
| US-12630783-B2 | Muguet type fragrance compounds | SYMRISE AG (DE) | 2026-05-19 | — | — | US | disclosed |
| US-12625123-B2 | Device and method for the analytical and sensory determination of the release of an active substance from a release system | SYMRISE AG (DE) | 2026-05-12 | — | — | US | disclosed |
| EP-4192614-B1 | PROCESS FOR THE PREPARATION OF MICROCAPSULES | SYMRISE AG (DE) | 2026-05-06 | — | — | EP | disclosed |
| EP-4724434-A1 | AMBERGRIS ISOMERS AND MIXTURES THEREOF | Symrise AG (DE) | 2026-04-15 | — | — | EP | disclosed |
| US-12583833-B2 | Enrichment of a diastereomer in Magnolan | SYMRISE AG (DE) | 2026-03-24 | — | — | US | disclosed |
| US-12577495-B2 | Fragrance mixtures containing 1-(4,4-dimethylcyclohexen-1-yl) ethanon | SYMRISE AG (DE) | 2026-03-17 | — | — | US | disclosed |
| US-12552732-B2 | Cyclopropanated sandalwood type compounds | SYMRISE AG (DE) | 2026-02-17 | — | — | US | disclosed |
| EP-4687810-A1 | PREPARATIONS COMPRISING HYDROXY PINACOLONE RETINOATE | Symrise AG (DE) | 2026-02-11 | — | — | EP | disclosed |
| US-7534908-B2 | Method for the production of optically active 3-alkylcarboxylic acids and the intermediate products thereof | WACKER CHEMIE AG (DE) | 2009-05-19 | — | — | US | disclosed |
| US-20070225519-A1 | Method for the Production of Optically Active 3-Alkyl Carboxylic Acids and the Intermediate Products Thereof | CONSORTIUM FUER ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 2007-09-27 | — | — | US | disclosed |
| EP-1537174-A1 | CYCLODEXTRIN PARTICLE | Symrise GmbH & Co. KG (DE) | 2005-06-08 | — | — | EP | disclosed |
| US-6844302-B1 | Encapsulated flavor and fragrance | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2005-01-18 | — | — | US | disclosed |
| WO-2004022642-A1 | CYCLODEXTRIN PARTICLE | SYMRISE GMBH & CO. KG (DE) | 2004-03-18 | — | — | WO | disclosed |
| WO-2004002930-A1 | ODORIFEROUS SUBSTANCES AND METHOD FOR THE PRODUCTION THEREOF | SYMRISE GMBH & CO. KG (DE) | 2004-01-08 | — | — | WO | disclosed |
| US-6369110-B1 | PROPHYLACTIC AGENT FOR DISEASES CAUSED BY THE ACCELERATION OF THE SODIUM/PROTON EXCHANGE TRANSPORT SYSTEM | SUMITOMO PHARMACEUTICALS COMPANY (JP) | 2002-04-09 | — | — | US | disclosed |
| EP-1083166-A1 | NOVEL SUBSTITUTED GUANIDINE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2001-03-14 | — | — | EP | disclosed |
| EP-0315071-B1 | Benzocyclohepten derivatives, their preparation and utilisation for pharmaceutics | HOFFMANN LA ROCHE (CH) | 1994-07-20 | — | — | EP | disclosed |
| US-4992574-A | Skin disorders, antiallergens, antiinflammatory agent | HOFFMANN-LA ROCHE INC. (US) | 1991-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12583833-B2 | Enrichment of a diastereomer in Magnolan | TRPA1, ENO1, ADH1A | TSHR 1897/4885MMP12 3775/4885MMP2 4308/4885 |
| US-12577495-B2 | Fragrance mixtures containing 1-(4,4-dimethylcyclohexen-1-yl) ethanon | ALG3, FAAH, FAAH2 | TSHR 4433/4885MMP12 4519/4885MMP2 4825/4885 |
| US-12630783-B2 | Muguet type fragrance compounds | MGAT1, RFT1, CPT1A | TSHR 4543/4885MMP12 4661/4885MMP2 3720/4885 |
| US-12625123-B2 | Device and method for the analytical and sensory determination of the release of an active substance from a release system | TAS2R7, TAS2R42, TAS2R39 | TSHR 1280/4885MMP12 3099/4885MMP2 959/4885 |
| US-12552732-B2 | Cyclopropanated sandalwood type compounds | FAAH2, ADCY10, OR10J3 | TSHR 4658/4885MMP12 4445/4885MMP2 4202/4885 |
| US-12630781-B2 | Fragrance or flavour mixture | NOTUM, FFAR2, FFAR1 | TSHR 1719/4885MMP12 3125/4885MMP2 3662/4885 |
| US-20070225519-A1 | Method for the Production of Optically Active 3-Alkyl Carboxylic Acids and the Intermediate Products Thereof | ME1, ME3, ACMSD | TSHR 2274/4885MMP12 1376/4885MMP2 1186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.